🇺🇸 FDA
Patent

US 8101380

Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs

granted A61PA61P25/00A61P25/18

Quick answer

US patent 8101380 (Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs) held by The United States of America, as represented by the Secretary, Health and Human Services expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Health and Human Services
Grant date
Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P25/00, A61P25/18